Waltz to Serve on NIH Study Section
Susan Waltz, PhD, professor of cancer biology and member of both the Cincinnati Cancer Center and the UC Cancer Institute, has been asked to serve on the Cancer Molecular Pathology Study Section for the National Institutes of Health, for the term beginning July 1, 2014 and ending June 30, 2020.
The Cancer Molecular Pathobiology [CAMP] Study Section reviews applications involving the pathology of the malignant cell with the emphasis on mechanisms controlling cell growth and death, and the molecular events in gene regulation.
Emphasis is on pathological approaches to oncogenesis and the basic cellular events involving growth of transformed cells in animal models, with more translational studies in human cells.
Tags
Related Stories
UC physician-researcher's work yields landmark five-year data for Crohn's disease drug
June 8, 2026
The University of Cincinnati College of Medicine’s Anita Afzali, MD, leads a landmark study revealing five-year efficacy and safety data for a Crohn’s disease drug called guselkumab.
Certain weather patterns can trigger migraines
June 8, 2026
Certain weather patterns really do trigger migraine headaches — and the incidence is more common in the Midwest. As WGN 9 in Chicago recently reported, researchers at the University of Cincinnati College of Medicine have identified two specific weather patterns associated with an increased risk of headaches.
UC expert weighs in on current MASH treatment approaches
June 5, 2026
As MedCentral recently reported, pending broader pharmacologic approvals for metabolic dysfunction-associated steatohepatitis (MASH), lifestyle modifications remain the go-to intervention.